Masanori Sakayori

Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy.

M. Oya, N. Shigematsu, Shinya Sutani, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Plan reproducibility of intraoperatively custom-built linked seeds compared to loose seeds for prostate brachytherapy

N. Shigematsu, Shinya Sutani, T. Ohashi, 2018, Journal of contemporary brachytherapy.

Quantitative analysis of genitourinary toxicity after iodine-125 brachytherapy for localized prostate cancer: Followup of the International Prostate Symptom Score and Overactive Bladder Symptom Score.

N. Shigematsu, Shinya Sutani, T. Ohashi, 2017, Brachytherapy.

Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trial

N. Shigematsu, Shinya Sutani, T. Ohashi, 2020, Journal of radiation research.

Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer

M. Oya, Tomoki Tanaka, N. Shigematsu, 2018, Cancer medicine.

Five-year potency preservation after iodine-125 prostate brachytherapy

N. Shigematsu, Kayo Yoshida, T. Ohashi, 2014, International Journal of Clinical Oncology.